Latin America and the Caribbean: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Latin America and the Caribbean

After two years of decline, the Latin American medicaments containing insulin market increased by X% to $X in 2023. In general, consumption, however, continues to indicate a abrupt contraction. The level of consumption peaked at $X in 2013; however, from 2014 to 2023, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Latin America and the Caribbean

In value terms, medicaments containing insulin production expanded slightly to $X in 2023 estimated in export price. Over the period under review, production, however, continues to indicate a pronounced descent. The pace of growth appeared the most rapid in 2013 with an increase of X%. As a result, production attained the peak level of $X. From 2014 to 2023, production growth remained at a lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Medicaments Containing Insulin Exports

Exports in Latin America and the Caribbean

In 2023, approx. X tons of medicaments containing insulin but not antibiotics were exported in Latin America and the Caribbean; which is down by X% compared with 2022. Overall, exports saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2022 when exports increased by X% against the previous year. The volume of export peaked at X tons in 2017; however, from 2018 to 2023, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports declined remarkably to $X in 2023. In general, exports showed a abrupt setback. The pace of growth appeared the most rapid in 2022 when exports increased by X%. Over the period under review, the exports reached the peak figure at $X in 2017; however, from 2018 to 2023, the exports failed to regain momentum.

Exports by Country

In 2023, Brazil (X tons) was the main exporter of medicaments containing insulin but not antibiotics, comprising X% of total exports. It was distantly followed by Panama (X kg), achieving a X% share of total exports.

Brazil was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of X% from 2012 to 2023. Panama (X%) illustrated a downward trend over the same period. Brazil (X p.p.) significantly strengthened its position in terms of the total exports, while Panama saw its share reduced by X% from 2012 to 2023, respectively.

In value terms, the largest medicaments containing insulin supplying countries in Latin America and the Caribbean were Brazil ($X) and Panama ($X).

Panama, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, in terms of the main exporting countries over the period under review.

Export Prices by Country

In 2023, the export price in Latin America and the Caribbean amounted to $X per ton, increasing by X% against the previous year. Overall, the export price, however, saw a deep setback. The pace of growth was the most pronounced in 2013 an increase of X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2014 to 2023, the export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Panama ($X per ton), while Brazil totaled $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Panama (X%).

Medicaments Containing Insulin Imports

Imports in Latin America and the Caribbean

In 2023, purchases abroad of medicaments containing insulin but not antibiotics was finally on the rise to reach X tons after two years of decline. Overall, imports, however, showed a abrupt downturn. The pace of growth was the most pronounced in 2015 when imports increased by X% against the previous year. Over the period under review, imports reached the maximum at X tons in 2018; however, from 2019 to 2023, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2023. Over the period under review, imports, however, recorded a deep slump. The most prominent rate of growth was recorded in 2015 when imports increased by X%. As a result, imports attained the peak of $X. From 2016 to 2023, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2023, Brazil (X tons) was the largest importer of medicaments containing insulin but not antibiotics, comprising X% of total imports. It was distantly followed by Guatemala (X kg), Saint Vincent and the Grenadines (X kg), Trinidad and Tobago (X kg), Panama (X kg) and El Salvador (X kg), together making up a X% share of total imports. Honduras (X kg) followed a long way behind the leaders.

From 2012 to 2023, average annual rates of growth with regard to medicaments containing insulin imports into Brazil stood at X%. At the same time, El Salvador (X%), Saint Vincent and the Grenadines (X%) and Guatemala (X%) displayed positive paces of growth. Moreover, El Salvador emerged as the fastest-growing importer imported in Latin America and the Caribbean, with a CAGR of X% from 2012-2023. By contrast, Trinidad and Tobago (X%), Honduras (X%) and Panama (X%) illustrated a downward trend over the same period. Brazil (X p.p.), Guatemala (X p.p.), Saint Vincent and the Grenadines (X p.p.) and El Salvador (X p.p.) significantly strengthened its position in terms of the total imports, while Honduras and Panama saw its share reduced by X% and X% from 2012 to 2023, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Brazil ($X), Panama ($X) and El Salvador ($X) were the countries with the highest levels of imports in 2023, with a combined X% share of total imports.

El Salvador, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Latin America and the Caribbean stood at $X per ton in 2023, with an increase of X% against the previous year. Over the period under review, the import price, however, showed a perceptible decrease. The most prominent rate of growth was recorded in 2014 when the import price increased by X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2015 to 2023, the import prices remained at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Panama ($X per ton), while Guatemala ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Trinidad and Tobago (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform